Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer. (Q33994406)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer. |
scientific article |
Statements
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer (English)
A F Hezel
M S Noel
J N Allen
T A Abrams
M Yurgelun
J E Faris
L Goyal
J W Clark
L S Blaszkowsky
J E Murphy
H Zheng
G C Connolly
O Hyrien
M Herr
K Ng
S Sheehan
D J Harris
E Regan
D R Borger
A J Iafrate
C Fuchs
D P Ryan
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference